Lymphoplasmacytic Lymphoma Recruiting Phase 2 Trials for Mycophenolate mofetil (DB00688)

Indication	Status	Phase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00719888	Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease	Treatment	Cyclophosphamide (DB00531) Cyclosporine (DB00091) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Thiotepa (DB04572)
NCT04195633	Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies	Treatment	Cyclophosphamide (DB00531) Cyclosporine (DB00091) Filgrastim (DB00099) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Mycophenolic acid (DB01024) Treosulfan (DB11678)
NCT02722668	UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep	Treatment	Cyclophosphamide (DB00531) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Sirolimus (DB00877)
NCT02661035	Allo HSCT Using RIC for Hematological Diseases	Treatment	Allopurinol (DB00437) Cyclophosphamide (DB00531) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864)